Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
10.90
Nov 05 • 3:59 PM ET Dollar change-0.70 Percentage change(-6.03%)
Aftermarket Close
11.05
Aftermarket • 7:43 PM ET Dollar change+0.15 Percentage change(1.38%)
Nov 05, 6:21 AMTrulieve Cannabis reports Q3 non-GAAP EPS $0.09, revenue $230.2M and 39% adjusted EBITDA margin, receives final DEA registrations under new federal Schedule III framework
Index
-
Market Cap
2.10B
Enterprise Value
2.35B
Income
-473.30M
Sales
1.14B
Book/sh
3.99
Cash/sh
1.69
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
5000
IPO
Sep 27, 2018
P/E
-
Forward P/E
29.14
PEG
-
P/S
1.84
P/B
2.73
P/C
6.45
P/FCF
10.89
EV/EBITDA
7.19
EV/Sales
2.06
Quick Ratio
3.98
Current Ratio
5.94
Debt/Eq
0.75
LT Debt/Eq
0.72
Option/Short
Yes / Yes
EPS (ttm)
-2.46
EPS next Y
0.37
EPS next Q
0.07
EPS this Y
-217.38%
EPS next Y
119.32%
EPS next 5Y
-
EPS past 3/5Y
22.54% -
Sales past 3/5Y
-1.02% 17.76%
EPS Y/Y TTM
-177.39%
Sales Y/Y TTM
-3.90%
EPS Q/Q
-2821.78%
Sales Q/Q
-10.31%
Insider Own
15.55%
Insider Trans
-5.37%
Inst Own
17.88%
Inst Trans
26.38%
ROA
-18.72%
ROE
-46.96%
ROIC
-35.90%
Gross Margin
49.43%
Oper. Margin
13.75%
Profit Margin
-41.55%
SMA20
2.35%
SMA50
-2.66%
SMA200
22.81%
Trades
Shs Outstand
169.98M
Shs Float
162.61M
52W High
13.28 -17.92%
52W Low
4.62 136.14%
Volatility
7.76% 6.58%
ATR (14)
0.73
RSI (14)
50.37
Beta
1.92
Rel Volume
0.86
Avg Volume
1.74M
Volume
1,496,502
Perf Week
2.83%
Perf Month
1.11%
Perf Quarter
24.57%
Perf Half Y
17.08%
Perf YTD
25.43%
Perf Year
61.00%
Perf 3Y
128.27%
Perf 5Y
-61.07%
Perf 10Y
-
Prev Close
11.60
Price
10.90
Change %
-6.03%
Consensus
Strong Buy
Avg. Price Target
$18.18
Implied Upside
+66.8%
Analysts1incl. previous ratings
Rating Distribution1 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jul 20, 2026Initiated
CCantor Fitzgerald
Overweight$15+37.6%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rivers Kim A.Chairman and CEOJun 26 '26Sale8.76136,8111,197,9171,476,913Jun 26 04:38 PM
Rivers Kim A.Chairman and CEOJun 24 '26Sale8.17400,0003,267,6001,913,724Jun 25 07:42 PM
Rivers Kim A.Chairman and CEOJun 23 '26Sale8.47380,0003,218,2202,313,724Jun 25 07:42 PM
Rivers Kim A.Chairman and CEOJun 25 '26Sale8.17300,0002,450,7001,613,724Jun 25 07:42 PM
Rivers Kim A.Chairman and CEOJun 22 '26Sale9.35204,8151,915,8402,693,724Jun 22 06:04 PM
Rivers Kim A.Chairman and CEOJun 18 '26Sale9.46139,8461,322,9432,898,539Jun 22 06:04 PM
Rivers Kim A.Chairman and CEOJun 17 '26Sale9.36137,5351,287,1903,038,385Jun 22 06:04 PM
Rivers Kim A.OfficerJun 17 '26Proposed Sale10.501,699,00717,839,574Jun 17 09:45 AM
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
FounderMs. Kimberly Rivers J.D.
Chief Financial OfficerMr. Jan Reese
J.D.Mr. Eric Raymond Powers III
Chief Production OfficerMr. Kyle Landrum
Chief Accounting OfficerMr. Brett Walsh